Transient Splicing Inhibition Causes Persistent DNA Damage and Chemotherapy Vulnerability in Triple-Negative Breast Cancer

Researchers identified the spliceosome U2 small nuclear ribonucleoprotein particle complex as a modulator of chemotherapy efficacy in TNBC.